Ignite Creation Date:
2024-05-06 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 2:16 PM
Study NCT ID:
NCT05086692
Status:
RECRUITING
Last Update Posted:
2024-03-29
First Post:
2021-09-10
Brief Title:
A Beta-only IL-2 ImmunoTherapY Study
Sponsor:
Medicenna Therapeutics Inc
Organization:
Medicenna Therapeutics Inc
Organization Data
Organization:
Medicenna Therapeutics Inc
Class:
INDUSTRY
Study ID:
MDNA11-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Medicenna Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |